YongJie Xin
发表
Jie Tian,
Kun Wang,
Ligong Lu,
2018,
Nanomedicine.
Ligong Lu,
Jingchao Li,
Meixiao Zhan,
2021
.
Meixiao Zhan,
Xu He,
Xinfeng Tang,
2021,
Biomaterials science.
Y. Ruan,
Jiahui Wang,
Ping Wang,
2022,
Advanced genetics.
G. Shulman,
R. Flavell,
Xiaoyong Yang,
2021,
Nature.
Ligong Lu,
Meixiao Zhan,
K. van Leyen,
2021,
Journal of Neurochemistry.
S. Shen,
Ligong Lu,
Meixiao Zhan,
2020,
Advanced Functional Materials.
Fa-zhong He,
Zhi-ling Zhou,
YongJie Xin,
2021,
Annals of translational medicine.
Fujun Zhang,
Meixiao Zhan,
Xu He,
2021
.
Ligong Lu,
Meixiao Zhan,
Xu He,
2021
.
Ligong Lu,
Meixiao Zhan,
Shaojun Peng,
2019,
Polymer Chemistry.
Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development
Yu Zhang,
Meixiao Zhan,
Xu He,
2022,
Frontiers in Oncology.
Minshan Chen,
Meixiao Zhan,
Xu He,
2019,
Artificial cells, nanomedicine, and biotechnology.
S. Yuan,
Li Sun,
YongJie Xin,
2021,
Clinical and Translational Oncology.
Kai Chen,
Meixiao Zhan,
Xu He,
2017,
Oncology letters.
Ligong Lu,
Meixiao Zhan,
Xu He,
2020,
Biochemical and biophysical research communications.
L. Luo,
Ligong Lu,
Meixiao Zhan,
2018,
Molecular medicine reports.
LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.
Ligong Lu,
Meixiao Zhan,
Xu He,
2019,
American journal of translational research.
X. Yi,
Y. Guan,
Ligong Lu,
2020,
Journal of gastrointestinal oncology.
C. Liang,
Zaiyi Liu,
Meng Li,
2016,
Medicine.
S. Shen,
Ligong Lu,
Meixiao Zhan,
2020,
Acta pharmaceutica Sinica. B.
Ligong Lu,
Meixiao Zhan,
Wei Li,
2020,
Theranostics.